CKD (Chronic Kidney Disease)

This is a long-term condition where your kidneys aren't working well for a significant amount of time, usually over three months. It's a gradual process. The kidneys continue to lose function slowly over months or years. This is a more serious stage than temporary kidney problems.

Condition

What people with CKD (Chronic Kidney Disease) report

Every report comes from a Lived member, sent anonymously.

Have you tried Farxiga (Dapagliflozin) for CKD (Chronic Kidney Disease)?

NameHow it went

About CKD (Chronic Kidney Disease)

What It Is

Chronic kidney disease (CKD) means the kidneys are damaged or are filtering blood less well than they should, and the problem has lasted at least three months. Healthy kidneys clean waste and extra fluid out of the blood as urine. They also keep minerals such as potassium in balance, help control blood pressure and make hormones that support bones and red blood cells. As filtering falls behind, waste and fluid can build up and those other jobs begin to slip. CKD is common. More than 1 in 7 US adults, roughly 35 million people, have it, and most do not know, because early CKD usually causes no symptoms. Blood and urine tests are the only reliable way to find it. It typically develops slowly over years. Some people keep stable kidney function for a long time, while others progress to kidney failure, when dialysis or a transplant is needed to do the kidneys' work. CKD also raises the risk of heart attack and stroke, so care aims to protect the heart as well as the kidneys. When symptoms appear, usually at later stages, they can include swelling in the legs, ankles or feet, tiredness, poor appetite or nausea, itchy or dry skin, muscle cramps, trouble sleeping or concentrating, foamy urine and changes in how often you urinate.

Causes & Risk Factors

Diabetes and high blood pressure cause most CKD in adults. Years of high blood sugar damage the kidneys' tiny filters, and high blood pressure damages the blood vessels that feed them. Because damaged kidneys hold on to extra fluid, which pushes blood pressure higher still, the two problems can feed each other. Other causes include diseases that inflame or scar the filters (glomerular diseases such as IgA nephropathy), autoimmune conditions such as lupus, polycystic kidney disease and other inherited conditions, kidney stones or infections with complications, narrowing of the arteries to the kidneys, and medicines that injure the kidneys. A past episode of acute kidney injury, a sudden loss of kidney function from illness, injury or medication, also raises the risk. Risk is higher with age over 65, heart disease or heart failure, obesity, smoking and a family history of kidney disease. African American, Hispanic, American Indian, Native Hawaiian and Pacific Islander people are more likely to reach kidney failure, partly because diabetes and high blood pressure are more common in these groups. CKD usually reflects a combination of factors rather than one, and identifying the specific cause matters because some causes have their own treatments.

How It's Diagnosed

Two routine tests find and track CKD. The first is a blood test for creatinine, a waste product from normal muscle activity that healthy kidneys clear. A formula turns the creatinine level into an eGFR (estimated glomerular filtration rate), which estimates how much blood the kidneys filter each minute. An eGFR of 60 or more is in the normal range, although CKD can still be present if urine tests or imaging show kidney damage. Below 60 for three months or longer points to CKD, and under 15 is kidney failure. Because creatinine depends partly on muscle mass and diet, clinicians sometimes add a second blood marker, cystatin C, when the result might be misleading, for example in people with very high or very low muscle mass. The second is a urine test called the urine albumin-to-creatinine ratio (uACR). Albumin is a protein that healthy kidneys keep in the blood, so finding it in urine is an early sign of damage. A result under 30 mg/g is normal, and 30 or more can signal kidney disease even when eGFR is still normal. An abnormal result is usually repeated to confirm it. Together these results set the stage. eGFR stages run from G1 (90 or higher, with signs of damage) and G2 (60 to 89, with damage) through G3a (45 to 59), G3b (30 to 44), G4 (15 to 29) and G5 (under 15). Albumin is graded A1 (under 30), A2 (30 to 300) or A3 (over 300). A report such as G3a A2 combines both, and higher albumin raises the risk of progression at any eGFR. A kidney ultrasound or other imaging can show the kidneys' size and structure, and a kidney biopsy is sometimes used to identify a specific disease.

Treatment Options

Established kidney damage usually can't be reversed, but treatment can slow further loss, protect the heart and manage complications. Starting early makes the biggest difference. Blood pressure control is central. Current kidney guidelines suggest aiming for a top (systolic) number under 120 when blood pressure is measured carefully in the clinic, with a gentler goal for people who are frail or prone to falls. ACE (angiotensin-converting enzyme) inhibitors (names ending in -pril, such as lisinopril) and angiotensin receptor blockers, or ARBs (names ending in -sartan, such as losartan), are preferred, especially when albumin is in the urine, because they lower pressure inside the kidney's filters and can slow damage even in people without high blood pressure. Blood pressure, creatinine and potassium are checked within 2 to 3 weeks of starting or raising the dose, since these medicines can raise potassium. A small early rise in creatinine is expected. Both can harm a developing baby, so anyone who could become pregnant should discuss birth control and pregnancy plans with their clinician, and report a pregnancy promptly. SGLT2 (sodium-glucose cotransporter 2) inhibitors, such as dapagliflozin (Farxiga) and empagliflozin (Jardiance), began as diabetes pills and are now approved to lower the risk of declining kidney function, kidney failure and death from heart causes in adults with CKD at risk of progression, with type 2 diabetes or without diabetes. In one major trial of people with substantial albumin in the urine, the combined rate of serious kidney decline, kidney failure or death from kidney or heart causes fell from about 15% to 9% with dapagliflozin over about two and a half years. A small early dip in eGFR is expected, and genital yeast infections are the main common side effect. These medicines are not suitable for every cause of CKD. For people with type 2 diabetes and CKD, two more options can add protection. Finerenone (Kerendia), a nonsteroidal mineralocorticoid receptor antagonist that blocks a hormone driving scarring in the heart and kidneys, lowers the risk of kidney and heart events but can raise potassium, so blood tests continue. Semaglutide (Ozempic), a weekly injected GLP-1 (glucagon-like peptide 1) medicine, is approved to reduce kidney decline, kidney failure and heart-related death in this group. Blood sugar goals are set individually, usually an A1C (a blood test of average blood sugar over about three months) below a level between 6.5% and 8%. Most adults with CKD who are not on dialysis also benefit from a statin to lower cholesterol and heart risk. Daily habits support all of this: eating less sodium, staying active, reaching a healthy weight and not smoking. A dietitian can tailor eating as CKD advances, which may mean adjusting protein, potassium or phosphorus based on blood tests. Common pain relievers called NSAIDs (nonsteroidal anti-inflammatory drugs), including ibuprofen (Advil, Motrin) and naproxen (Aleve), can injure the kidneys, so check over-the-counter medicines and supplements with a pharmacist. Some prescription doses need lowering as kidney function falls. Complications such as anemia, bone and mineral problems and high potassium are found through blood tests and treated as they arise. If the kidneys fail, the options are hemodialysis, peritoneal dialysis (done at home using the lining of the abdomen as a filter) or a kidney transplant. Some people choose conservative care, continuing medicines and support without dialysis.

What to Expect

The course of CKD varies widely. Many people live for years with stable kidney function, while others decline faster, depending on the cause, how much albumin is in the urine, and how well blood pressure and blood sugar are controlled. For most people, especially in earlier stages, living with CKD is less about symptoms than about routine: taking medicines consistently, keeping an eye on blood pressure and attending regular checkups. Follow-up centers on the same blood and urine tests used for diagnosis. The goal is to keep eGFR steady and urine albumin the same or lower, and comparing each result with the last one shows whether the plan is working. Tests become more frequent as CKD advances, and medicines often change over time. A referral to a kidney specialist (nephrologist) is common when CKD is advanced, getting worse quickly or complicated. In later stages, eating patterns may become more restricted and symptoms such as fatigue, itching or poor appetite are more common. Planning for possible kidney failure works best well before it is needed, so there is time to compare dialysis types, transplant evaluation and conservative care, and to protect the arm veins that might later be used for dialysis. Many people on dialysis or with a transplant continue to work and lead active lives. Living with a long-term condition can be stressful, and depression is worth raising with the care team.

When to Seek Help

Ask about kidney testing if you have diabetes (at least once a year), high blood pressure, heart disease or a family history of kidney failure, since early CKD gives no warning signs. If you already have CKD, check with your care team or pharmacist before starting any new medicine, including pain relievers and supplements. Contact your care team if you notice increasing swelling in your legs or feet, a change in how much or how often you urinate, loss of appetite, nausea or vomiting, new itching, or trouble sleeping or concentrating, or if home blood pressure readings stay above your target. Call promptly if vomiting or diarrhea keeps you from eating or drinking, since some kidney and blood pressure medicines may need to be paused. A very fast or pounding heartbeat, chest pain or sudden shortness of breath can signal a dangerously high potassium level or a serious buildup of fluid, and needs emergency care right away.

Questions to Ask Your Doctor

  1. 1.What are my eGFR and urine albumin results, what stage does that put me in, and how have they changed since my last tests?
  2. 2.What is causing my kidney disease, and does that cause need any specific treatment?
  3. 3.Would an SGLT2 inhibitor or another kidney-protecting medicine help me, and what monitoring would it require?
  4. 4.Which of my current medicines, pain relievers or supplements need a dose change or should I avoid?
  5. 5.When should I see a kidney specialist, and when should we start planning for options such as dialysis or a transplant?

Last reviewed • Oct 2026

Educational content, not medical advice.